CD86 and melanoma: However, aPD-1 treatment reduced the number of intratumoral F4/80+CD86+ M1 macrophages, but HLS@SVMAV did not exert a significant influence on M1 macrophages (online supplemental figure S7A, B), which is consistent with the observations in the melanoma model (online supplemental figure S6C, F).